| ACT | Adoptive cell transfer |
| AKT | protein kinase B |
| APCs | Antigen presenting cells |
| ATP | Adenosine triphosphate |
| B-ALL | B cell acute lymphoblastic leukemia |
| Bcl-X(L) | B-cell lymphoma-extra large |
| CAFs | Cancer-associated fibroblasts |
| CAR | Chimeric antigen receptor |
| CAR-M | Chimeric antigen receptor macrophage |
| CAR-Ps | Chimeric antigen receptors for phagocytosis |
| CAT | Catalase |
| CCR | Chimeric costimulatory receptor |
| CLL | Chronic lymphocytic leukemia |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| CRS | Cytokine release syndrome |
| ECM | Extracellular matrix |
| ETBR | Endothelin B receptor |
| FAO | Fatty acid oxidation |
| GLUT1 | Glucose transporter 1 |
| HER2 | Human epidermal growth factor receptor 2 |
| HK | Hexokinase 2 |
| HPSE | Heparinase |
| HSPG | Heparan sulphate proteoglycans |
| ICOS | Inducible T cell co-stimulator |
| IDO | Indoleamine-2,3-dioxygenase |
| IL-10 | Interleukin 10 |
| LBCL | Large B cell lymphoma |
| MDSC | Myeloid-derived suppressor cells |
| MICA | Major histocompatibility complex class I polypeptide-related sequence A |
| NK | Natural killer |
| OXPHOS | Oxidative phosphorylation |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed cell death ligand 1 |
| PFK-6 | phosphofructo-2-kinase |
| PGC1-α | PPAR-gamma coactivator 1-α |
| PGE2 | Prostaglandin E2 |
| PI3K | Phosphoinositide 3-kinase |
| PSMA | Prostate-specific membrane |
| ROS | Reactive oxygen species |
| ScFv | Single chain variable fragment |
| TAA | Tumor-associated antigens |
| TCR | T cell receptor |
| TGFβ | Transforming growth factor beta |
| TILs | Tumor-infiltration lymphocytes |
| TME | Tumor microenvironment |
| VEGF | Vascular endothelial growth factor |